Overview
- 3 inspections across 3 sites are on record.
- 12 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2024-05-03.
At a glance
Inspections
3
Sites
3
Observations
12
Career since
Jun 2017
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Avista Pharma Solutions, Inc. dba Cambrex | 3 May 2024 | Human Drugs | View 483 → |
| Nephron SC, LLC | 9 Feb 2024 | Human Drugs | View 483 → |
| Delta Air Lines, Inc. | 29 Jun 2017 | Foods & Cosmetics |
Sites inspected
Avista Pharma Solutions, Inc. dba CambrexLongmont, United States1 insp.
Nephron SC, LLCWest Columbia, United States1 insp.
Delta Air Lines, Inc.Detroit, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Cecilia H Kieu1 shared
David J Gomes1 shared
Miguel A Martinez1 shared
Nicholas L Hunt1 shared
Walden H Lee1 shared
Santos E Camara1 shared
Maria C Iuga1 shared
Marlon K Turner1 shared
Full investigator report
Get the verbatim findings behind Michael S Budziak's 12 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site